Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Clinical trial NCT04566328 · RECRUITING

Trial details

NCT number: NCT04566328
Sponsor: ECOG-ACRIN Cancer Research Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Plasma Cell Myeloma RISS Stage I Plasma Cell Myeloma RISS Stage II Plasma Cell Myeloma

Start date: 2021-02-24
Primary completion: 2027-12-31
Enrollment: 1450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.